Tokyo, Japan

Azusa Terao

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Azusa Terao: Innovator in PIVKA-II Measurement Technology

Introduction

Azusa Terao is a notable inventor based in Tokyo, Japan. She has made significant contributions to the field of medical diagnostics, particularly in the measurement of PIVKA-II, a crucial biomarker in various health conditions. Her innovative approach has led to the development of a patented measurement method that enhances the accuracy of serum-plasma correlation.

Latest Patents

Azusa Terao holds a patent for the "PIVKA-II measurement method, measurement reagent, and measurement kit." This invention discloses a method that achieves better serum-plasma correlation than conventional techniques. The method involves measuring PIVKA-II in a sample through an immunoassay, utilizing a mixture of specific antibodies that target prothrombin fragments and PIVKA-II itself. This advancement is expected to improve diagnostic accuracy in clinical settings.

Career Highlights

Throughout her career, Azusa Terao has worked with prominent companies in the medical field, including Fujirebio Inc. and Sekisui Medical Co., Ltd. Her experience in these organizations has allowed her to refine her skills and contribute to significant advancements in medical technology.

Collaborations

Azusa has collaborated with esteemed colleagues such as Kentaro Yamaguchi and Katsumi Aoyagi. These partnerships have fostered an environment of innovation and have played a crucial role in the development of her patented technologies.

Conclusion

Azusa Terao's contributions to the field of medical diagnostics through her innovative PIVKA-II measurement method exemplify her dedication to improving healthcare. Her work not only enhances diagnostic accuracy but also showcases the importance of collaboration in scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…